Pre Diagnostics

Next generation blood tests

Pre Diagnostics

Next generation
blood tests

Vision

A world where early detection enables treatment of patients with neurodegenerative disease before it’s too late

Contact us

Vision

A world where early detection enables treatment of patients with neurodegenerative disease before it’s too late

Contact us

An intracellular approach to diagnostics – changing the way diagnostics approach blood tests

Pre Diagnostics is the first diagnostics company to focus on intracellular measurements of disease-specific biomarkers inside the blood cells. We extract disease-relevant information from biomarkers located inside specific blood cells called monocytes to provide actionable results for patient and practitioner.

2

First product detects Alzheimer’s disease before clinical symptoms appear

Pre Diagnostic’s first test will enable early detection of Alzheimer’s disease with an accurate, non-invasive, dynamic test, where the ongoing clearance of beta amyloid (Abeta) is measured. Abeta is considered to be the first hallmark of Alzheimer’s disease, and our test is the only blood test that measures the ongoing disease pathology demonstrated by Abeta clearance.

4
maskin
imag5